Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM) (APM)

February 4, 2016 updated by: Young-Chul Kim, Chonnam National University Hospital

A Randomized Prospective Controlled Study of Active Pain Management in Lung Cancer Outpatients (APM)

This study is:

  • A single-center, randomized, prospective controlled trial.
  • To prove superiority of active pain management group compared to control group by the percent of pain intensity difference of outpatients with lung cancer pain.
  • 204 patients will be recruited.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  • The recruited patients in both group will be provided the education about pain-killer, and received medicines including opioids according to their numeric rating scale (NRS)
  • Active management group will be provided additional telephone counseling and dosage modification by specialized nurse for cancer pain.

  • The percent of pain intensity difference (%PID)

    • PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1

Study Type

Interventional

Enrollment (Actual)

79

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Korea, Republic of
      • Jeonnam, Korea, Republic of
        • Chonnam National University Hwasun Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Outpatients with lung cancer.
  • The patients with uncontrolled lung cancer pain - more than and equal NRS 4 pain during previous 24 hours for background pain, or more than and equal 3 times/day for breakthrough painkiller medication.
  • Over 20 year-old male or female.
  • The patients can be able to received telephone counseling by investigator's decision.

Exclusion Criteria:

  • Drug or alcohol abusers.
  • Child-bearing women or pregnant women.
  • The patients with moderate to severe psychiatric problems.
  • The patients who have hypersensitivity to opioids.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: active pain management
active pain management (APM) by specialized nurses for cancer pain
Behavioral: Active pain management
Active pain management will be provided by specialized pain nurse, such as telephone counseling for toxicity control and opioid dose modification.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The percent of pain intensity difference
Time Frame: visit 3 (6 to 8 weeks)

The percent of pain intensity difference (%PID)

%PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1
visit 3 (6 to 8 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patients' satisfaction score about pain management
Time Frame: visit 3 (6 to 8 weeks)
Qustionnaire of 5-point scale
visit 3 (6 to 8 weeks)
Eastern Cooperative Oncology Group (ECOG) Performance score
Time Frame: visit 3 (6 to 8 weeks)
ECOG performance status: 0,1,2,3,4
visit 3 (6 to 8 weeks)
Assessment of Korean Brief Pain Inventory score
Time Frame: visit 3 (6 to 8 weeks)
Qustionnaire; K-BPI(Korean Brief Pain Inventory)
visit 3 (6 to 8 weeks)
Investigator's global assessment score
Time Frame: visit 3 (6 to 8 weeks)
Qustionnaire of 5-point scale
visit 3 (6 to 8 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Chonnam National University Hospital

Collaborators

Janssen Korea, Ltd., Korea

Investigators

  • Study Chair: Young-Chul Kim, MD,PhD, Chonnam National University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

January 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

February 1, 2011

First Submitted That Met QC Criteria

March 7, 2011

First Posted (Estimate)

March 8, 2011

Study Record Updates

Last Update Posted (Estimate)

February 5, 2016

Last Update Submitted That Met QC Criteria

February 4, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PAIN_LCA_2011

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe